Pregabalin In Partial Seizures Extension Study

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

NCT00141388 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00150293 ·Status: COMPLETED ·Phase: PHASE3

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

NCT00596466 ·Status: COMPLETED ·Phase: PHASE3

Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures

NCT00524030 ·Status: TERMINATED ·Phase: PHASE3

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00141245 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

NCT00141414 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

NCT00448916 ·Status: COMPLETED ·Phase: PHASE3

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

NCT01463306 ·Status: COMPLETED ·Phase: PHASE3

Once-A-Day Pregabalin For Partial Seizures

NCT01262677 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

NCT00437281 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

NCT01389596 ·Status: COMPLETED ·Phase: PHASE3

A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.

NCT02072824 ·Status: COMPLETED ·Phase: PHASE3

A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.

NCT01747915 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

NCT00372528 ·Status: TERMINATED ·Phase: PHASE3

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NCT00280059 ·Status: COMPLETED ·Phase: PHASE3

Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline

NCT01309074 ·Status: WITHDRAWN ·Phase: PHASE4

Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency

NCT00684424 ·Status: COMPLETED

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

NCT01147003 ·Status: COMPLETED ·Phase: PHASE2

Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).

NCT00288639 ·Status: COMPLETED ·Phase: PHASE4

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

NCT00351611 ·Status: COMPLETED ·Phase: PHASE4

Phase II BGG492 Capsule Extension for Partial Epilepsy

NCT01338805 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study With Lyrica In Patients Suffering From Epilepsy

NCT00922987 ·Status: COMPLETED

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

NCT01002820 ·Status: COMPLETED ·Phase: PHASE2

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

NCT00175864 ·Status: WITHDRAWN ·Phase: PHASE3

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2